Skip to main content
. Author manuscript; available in PMC: 2007 Oct 16.
Published in final edited form as: Nicotine Tob Res. 2007 Feb;9(2):225–231. doi: 10.1080/14622200601078566

Figure 1.

Figure 1

Flowchart describing progress of patients through the Patch II Study. Participants enrolled in a randomized, placebo-controlled trial of nicotine replacement patch (Patch Trial) were recontacted 8 years after the trial for genotyping (Patch II Study). Numbers of subjects at each point of contact are indicated in the figure. *One participant in each treatment group was not successfully genotyped. **Smoking outcome data was missing for one participant of Caucasian ancestry.